Guidance
Skip Standards and indicators submenu
Quality standards
Our quality standards set out priority areas for quality improvement. They highlight areas with identified variation in current practice.
View our quality standards
How to use our quality standards
The timeline for developing quality standards
Help us develop quality standards
Selecting and prioritising quality standards topics
About quality standards
Indicators
Our indicators measure outcomes that reflect the quality of care, or processes linked by evidence to improved outcomes.
View list of indicators
Learn about the committee that develops indicators
About indicators
Skip Life sciences submenu
Life Sciences
We offer tailored support to industry during product development. Our expertise can help you build the evidence needed to achieve market access.
View life sciences
Get support from NICE
NICE Advice service
Trusted, unrivalled expertise.
Make an enquiry
Contact us to discuss your requirements.
Innovative Licensing and Access Pathway (ILAP)
Streamlining patient access to safe, financially sustainable and innovative medicines.
Learn how we evaluate technologies
Health technology evaluation and topic selection manuals
Updated manuals for methods, processes and topic selection.
Digital health technologies
Accelerating our efforts to deliver innovation to the health and care system.
Evidence standards framework
Using the best available evidence to develop recommendations that guide decisions in health, public health and social care.
Our guidance programmes
Ensuring new technologies are clinically effective and offer economic value.
Register your product
Non-pharmaceutical
NHS Innovation Service is a clear and simple point of entry for health technologies to access support and national evaluation programmes.
Pharmaceutical
UK PharmaScan is a database of new medicines, indications and formulations in the pharmaceutical pipeline.
Find published and proposed evaluations
Diagnostics
Guidance on measurements and tests used to evaluate a patient's condition.
Medical technologies
Guidance on medical technologies put forward to NICE by manufacturers.
Technology appraisals
Guidance on new and existing medicines and treatments in the NHS.
Highly specialised technologies
Guidance on the use of highly specialised medicines and treatments.
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
Skip About submenu
About
NICE helps practitioners and commissioners get the best care to patients, fast, while ensuring value for the taxpayer.
Explore about
Our programmes
Learn about the information we produce.
Guidance
Advice
Quality standards
Indicators
Digital health
Topic selection
Get involved
Understand how decisions are made:
Attend a committee meeting
Comment on draft guidance:
Guidance in consultation
Be part of a guidance committee:
Join a committee
Help develop our products:
Register as a stakeholder
Putting you at the heart of our work:
Public involvement
What we do
Social care
Life sciences
NICE international
Patient safety
Shared decision making
View all What we do
Into practice
Social care quick guides
Measuring the use of NICE guidance
Resource planner
View all Into practice
Who we are
The board
The NICE strategy 2021 to 2026
Corporate publications
View all Who we are
- Contact us
- Jobs

Tobacco: preventing uptake, promoting quitting and treating dependence

NICE guideline
Reference number: NG209
Published: 30 November 2021
Last updated: 04 February 2025

History

Guidance published

Equality and health inequalities assessment (PDF 329 KB)

Published:

04 February 2025
Committee member list (PDF 122 KB)

Published:

04 February 2025
Consultation comments and responses (PDF 495 KB)

Published:

04 February 2025
Supporting documentation - Acknowledgements (PDF 187 KB)

Published:

04 February 2025

Stakeholder list updated

Stakeholder list (PDF 253 KB)

Published:

03 February 2025

Declaration of interests

Register of interests (PDF 286 KB)

Published:

03 February 2025

Draft guidance consultation

Draft guidance consultation
Draft guideline (PDF 367 KB)

Published:

15 November 2024
Evidence review A (PDF 2.31 MB)

Published:

15 November 2024
Equality and health inequalities assessment 2 (PDF 193 KB)

Published:

15 November 2024
Comments form (MSWord 48 KB)

Published:

15 November 2024

Committee list updated

Committee member list (PDF 122 KB)

Published:

05 November 2024

Committee meetings

Committee meeting
Minutes 1 (PDF 114 KB)

Published:

04 October 2024

Scope published

Equality and health inequalities assessment 1 (PDF 276 KB)

Published:

27 September 2024
Final scope (PDF 207 KB)

Published:

26 November 2024

Update on 04 August 2022

Guidance published
Consultation comments and responses (PDF 1.2 MB)

Published:

04 August 2022
Equality impact assessment 4 (PDF 148 KB)

Published:

04 August 2022
Committee member list (PDF 137 KB)

Published:

04 August 2022
Stakeholder list updated
Stakeholder list (PDF 254 KB)

Published:

03 August 2022
Draft guidance consultation
Draft guidance consultation
Draft guideline (PDF 340 KB)

Published:

11 May 2022
Evidence review (PDF 2.04 MB)

Published:

11 May 2022
Committee member list (PDF 137 KB)

Published:

11 May 2022
Committee member list DOI (PDF 500 KB)

Published:

11 May 2022
Supporting evidence (PDF 181 KB)

Published:

11 May 2022
Confidentiality form (MSWord 41 KB)

Published:

11 May 2022
Equality impact assessment (PDF 166 KB)

Published:

11 May 2022
Pre-consultation documents released
Economic plan (PDF 131 KB)

Published:

05 April 2022
Review questions (PDF 148 KB)

Published:

05 April 2022
Search strategies (PDF 739 KB)

Published:

05 April 2022
Scope published
Final scope (PDF 167 KB)

Published:

18 January 2022
Committee member list (PDF 137 KB)

Published:

18 January 2022
Declaration of interests
Register of interests (PDF 512 KB)

Published:

04 August 2022

Original development on 30 November 2021

Guidance published
Guidance consultation comments and response (PDF 8.24 MB)

Published:

30 November 2021
Equality impact assessment (PDF 137 KB)

Published:

30 November 2021
Stakeholder list updated
Stakeholder list (PDF 313 KB)

Published:

04 October 2021
Declaration of interests
Register of interests (PDF 1.61 MB)

Published:

21 September 2021
Draft guidance consultation
Draft guidance consultation
Draft guideline (PDF 1.29 MB)

Published:

25 June 2021
Evidence review A&B (PDF 1.91 MB)

Published:

25 June 2021
Evidence review C&D (PDF 1.52 MB)

Published:

25 June 2021
Evidence review E (PDF 1.94 MB)

Published:

25 June 2021
Evidence review F&G (PDF 3.05 MB)

Published:

25 June 2021
Evidence review H (PDF 1.83 MB)

Published:

25 June 2021
Evidence review I (PDF 2.1 MB)

Published:

25 June 2021
Evidence review J (PDF 3.15 MB)

Published:

25 June 2021
Evidence review K - main (PDF 2.88 MB)

Published:

25 June 2021
Evidence review K - appendices (PDF 5.58 MB)

Published:

25 June 2021
Evidence review L (PDF 1.54 MB)

Published:

25 June 2021
Evidence review M (PDF 1.09 MB)

Published:

25 June 2021
Evidence review N (PDF 2.94 MB)

Published:

25 June 2021
Evidence review O (PDF 1.78 MB)

Published:

25 June 2021
Supporting documentation Methods (PDF 337 KB)

Published:

25 June 2021
Supporting documentation Model P (PDF 1.13 MB)

Published:

25 June 2021
Supporting documentation Model Q (PDF 1.82 MB)

Published:

25 June 2021
Supporting documentation Model R (PDF 1.32 MB)

Published:

25 June 2021
Supporting documentation Model S (PDF 866 KB)

Published:

25 June 2021
Supporting documentation Acknowledgements (PDF 219 KB)

Published:

25 June 2021
Committee member list (PDF 160 KB)

Published:

25 June 2021
Supporting documentation DOI (PDF 1.62 MB)

Published:

25 June 2021
Equality impact assessment 3 (PDF 133 KB)

Published:

25 June 2021
Comments form (MSWord 40 KB)

Published:

25 June 2021
Pre-consultation documents released
Search strategies (PDF 13.82 MB)

Published:

19 January 2021
Review questions (PDF 170 KB)

Published:

19 January 2021
Economic plan (PDF 124 KB)

Published:

19 January 2021
Committee list updated
Committee member list (PDF 155 KB)

Published:

17 July 2020
Call for evidence
Call for evidence
Call for evidence response form (MSWord 75 KB)

Published:

06 January 2020
Confidentiality form (MSWord 68 KB)

Published:

06 January 2020
Addendum Further information (MSWord 58 KB)

Published:

06 January 2020
Scope published
Final scope (PDF 477 KB)

Published:

12 September 2018
Consultation comments and responses Stakeholders (PDF 2.39 MB)

Published:

12 September 2018
Consultation comments and responses Respondents (PDF 1.26 MB)

Published:

12 September 2018
Equality impact assessment (PDF 152 KB)

Published:

12 September 2018
Draft scope consultation
Draft scope consultation
Comments form (MSWord 64 KB)

Published:

14 May 2018
Draft scope (PDF 517 KB)

Published:

14 May 2018
Equality impact assessment (PDF 376 KB)

Published:

14 May 2018
Committee meeting
Minutes 0 a/b (PDF 231 KB)

Published:

15 January 2019
Minutes 1 (PDF 169 KB)

Published:

12 February 2019
Minutes 2 & 3 (PDF 288 KB)

Published:

16 July 2019
Minutes 4 (PDF 215 KB)

Published:

02 July 2019
Minutes 5 (PDF 258 KB)

Published:

24 September 2019
Minutes 6 & 7 (PDF 276 KB)

Published:

07 November 2019
Minutes 8 & 9 (PDF 210 KB)

Published:

14 January 2020
Minutes 10 & 11 (PDF 234 KB)

Published:

04 March 2020
Minutes 12 (PDF 205 KB)

Published:

13 October 2020
Minutes 13 - Day 1 (PDF 192 KB)

Published:

04 November 2020
Minutes 13- Day 2 (PDF 176 KB)

Published:

05 November 2020
Minutes 14 (PDF 206 KB)

Published:

26 March 2021
Minutes 15 (PDF 221 KB)

Published:

01 September 2021